1 / 5

Global Myofascial Pain Syndrome (MPS) Treatment Market - Industry Trends and Forecast to 2028

Global Myofascial Pain Syndrome (MPS) Treatment Market

pawarmnk
Download Presentation

Global Myofascial Pain Syndrome (MPS) Treatment Market - Industry Trends and Forecast to 2028

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Myofascial Pain Syndrome (MPS) Treatment Market - Industry Trends and Forecast to 2028 Myofascial pain syndrome (MPS) treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 4.00% in the above-mentioned research forecast period. Rising geriatric population and increasing technological advancement for pain treatment will likely to drive the market growth. Moreover, increasing focus of market players towards the development of non-opioid treatment options, rising level of muscle and other stress and increasing awareness for disease cause and its treatment options also boost up the market growth. Moreover, increasing research and development and rising healthcare expenditure act as opportunities for the market growth. But, sometimes adverse effect related to the drugs, strict regulatory framework and high cost of laser therapy among other may hamper the global myofascial pain syndrome (MPS) treatment market. https://www.databridgemarketresearch.com/reports/global-myofascial-pain-syndrome-mps-treatment-market

  2. Report Description https://www.databridgemarketresearch.com/reports/global-myofascial-pain-syndrome-mps-treatment-market Myofascial pain syndrome (MPS) is a kind of musculoskeletal disorder that causes chronic pain in several body parts and sites.  The primary source of myofascial syndrome is myofascial trigger points and is responsible for production of localized or referred pain. Myofascial trigger points arises from the abnormal stress imposed on muscle fibres which can be the result of repetitive microtrauma or traumatic injury. Fibromyalgia and sleep problems are most common complications associated with myofascial pain syndrome. The most common symptoms associated with this disease involves deep, aching pain in muscle, a kind of tender knot in muscle, difficulty in sleeping among others. Myofascial pain syndrome can effectively be treated by the application of pain medications, relaxation techniques, physical therapy and trigger point injections among others. As per the report published by WHO on November 2019, this has been suggested that musculoskeletal condition is one of the leading causes of disability worldwide which varies with age and diagnosis. It accounts for approximately 20% to 30% of overall worldwide population. The affected population is largely dependent upon the effective treatments and therapies hence expected to provide market with the lucrative growth. It is also estimated that myofascial pain syndrome (MPS) treatment market is growing with the CAGR of 4.00% in 2020.

  3. Market Segmentation • Global Myofascial Pain Syndrome (MPS) Treatment Market Scope and Market Size • Myofascial pain syndrome (MPS) treatment market is segmented on the basis of treatment, route of administration, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets. • On the basis of treatment, the myofascial pain syndrome (MPS) treatment market is segmented into pharmacologic treatment and non- pharmacologic treatment. • On the basis of route of administration, the myofascial pain syndrome (MPS) treatment market is segmented into oral, parenteral, topical and others. • On the basis of end-users, the myofascial pain syndrome (MPS) treatment market is segmented into clinics, hospitals, homecare and others. • On the basis of distribution channel, the myofascial pain syndrome (MPS) treatment market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.  • https://www.databridgemarketresearch.com/toc/?dbmr=global-myofascial-pain-syndrome-mps-treatment-market

  4. Key Players Competitive Landscape and Myofascial pain syndrome (MPS) Treatment Market Share Analysis Myofascial pain syndrome (MPS) treatment market competitive landscape provides details by competitor. details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Myofascial pain syndrome (MPS) treatment market. The major players covered in the Myofascial pain syndrome (MPS) treatment market report are Bliss GVS Pharma Limited, SAMYANG BIOPHARMACEUTICALS COPORATION, Jenburkt Pharmaceuticals Limited, Nemaura, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Acino International AG, Sun Pharmaceutical Industries Ltd., Avenue Therapeutics, Janssen Scientific Affairs, LLC, Dr. Reddy’s Laboratories Ltd., Teikoku Pharma USA, Inc., SCILEX Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Pfizer.Inc, Afton Pharma, Natco Pharma (Canada) Inc., Eli Lilly and Company, Aurobindo Pharma Limited, Cutting Edge Laser Technologies, Lightforce,  eToims, HOLLAR CHIROPRACTIC & RHAB among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

  5. About Data Bridge Market Research An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth  the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Read Continue : http://databridgemarketresearch.com/about-us/ Contact Us : SopanGedam Sopan.gedam@databridgemarketresearch.com

More Related